The COVID-19 pandemic has created renewed appreciation for the tremendous impact healthcare and pharmaceutical innovation has on the health and daily lives of society. Public-private partnerships to develop vaccines and therapeutics in response to the pandemic have significantly raised public awareness about clinical trials and global clinical trial infrastructure. Established clinical development paradigms in which...
Read More
The domain of EU-PEARL’s research, Integrated Research Platforms (IRPs) and platform trials is relatively new and consequently the vocabulary is still work in progress.  Hence, the need to develop a common understanding and usage of terminology beyond EU-PEARL. With this goal in mind, D2.1. Report on Terminology, References and Scenarios for Platform Trials and Master...
Read More

Sign up to stay informed

    We will process your data to deliver our quarterly updates to your inbox. You can view our Privacy Policy here or contact us at info@eu-pearl.eu